February 01, 2015 7:18 PM ET


Company Overview of Tikvah Therapeutics, Inc.

Company Overview

Tikvah Therapeutics, Inc., a biopharmaceutical company, focuses on the acquisition, development, and commercialization of therapeutic products for unmet medical needs and disorders relating to the central nervous system in Georgia. Its products include TIK-101 for treatment of anxiety disorders; and TIK-101, a formulation of an HDAC inhibitor, for possible treatment of spinal muscular atropy. The company was incorporated in 2005 and is based in Atlanta, Georgia.

75 Fifth Street, NW

Suite 207

Atlanta, GA 30308

United States

Founded in 2005





Key Executives for Tikvah Therapeutics, Inc.

Chief Medical Officer and Vice President of Research & Development
Deputy Chief Medical Officer and Executive Director of Clinical Research & Development
Vice President of Pharmaceutical Development
Compensation as of Fiscal Year 2014.

Similar Private Companies By Industry

Company Name Region
Axsome Therapeutics, Inc. United States
GynoPharma Inc. United States
Advenchen Laboratories, LLC United States
AltheRx Pharmaceuticals Inc. United States
Bristol-Myers Squibb Holdings Pharma Ltd. Liability Company United States

Recent Private Companies Transactions

No transactions available in the past 12 months.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Most Searched Private Companies

Company Name Geographic Region
NYC2012, Inc. United States
Lawyers Committee for Civil Rights Under Law United States
Bertelsmann AG Europe
Rush University United States
Greater Houston Partnership United States

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact Tikvah Therapeutics, Inc., please visit --. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.